Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

V. Klancik, L. Pesl, M. Neuberg, P. Tousek, V. Kocka

. 2022 ; 24 (Suppl B) : B16-B22. [pub] 20220330

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017493

Long-term follow-up after primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) beyond 5 years is poorly described. There are no risk-stratification systems available for routine use. This retrospective, academic, two-centre analysis included consecutive patients who presented with acute STEMI between March 2008 and December 2019. In total, 5263 patients underwent pPCI; all patients were included in the analysis only once. Baseline characteristics were gathered from prospective local registries and based on initial hospitalization. The study enrolled 5263 patients who had been treated with pPCI; it found that cardiovascular mortality was the most frequent cause of death (65.0%) on long-term follow-up to 12 years. Myocardial infarction associated mortality was 27.2%. Cardiovascular mortality was dominant, including in the landmark analysis beyond 1 year. Multivariate analysis identified significant predictors for long-term cardiovascular mortality: age, history of diabetes mellitus, history of renal insufficiency, history of heart failure, Killip class, and successful pPCI at presentation. A predictive model was built to evaluate the risk of cardiovascular death with a high discrimination value (C-statistic = 0.84). Cardiovascular diseases remain the leading cause of long-term mortality after pPCI in the Central European population. Our novel predictive model provides risk stratification; it could identify patients who would experience the greatest benefit from aggressive secondary prevention measures.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017493
003      
CZ-PrNML
005      
20220720100243.0
007      
ta
008      
220718s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurheartjsupp/suac003 $2 doi
035    __
$a (PubMed)35370501
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Klancik, Viktor $u Third Faculty of Medicine, Charles University, Prague, Ruska 2411, 100 00, Czech Republic $u Department of Cardiology, University Hospital Kralovske Vinohrady, Prague, Srobarova 50, 100 00, Czech Republic $u Department of Cardiology, Hospital Ceske Budejovice, a.s., Ceske Budejovice, B. Nemcove 585/54, 370 01, Czech Republic
245    10
$a Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention / $c V. Klancik, L. Pesl, M. Neuberg, P. Tousek, V. Kocka
520    9_
$a Long-term follow-up after primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) beyond 5 years is poorly described. There are no risk-stratification systems available for routine use. This retrospective, academic, two-centre analysis included consecutive patients who presented with acute STEMI between March 2008 and December 2019. In total, 5263 patients underwent pPCI; all patients were included in the analysis only once. Baseline characteristics were gathered from prospective local registries and based on initial hospitalization. The study enrolled 5263 patients who had been treated with pPCI; it found that cardiovascular mortality was the most frequent cause of death (65.0%) on long-term follow-up to 12 years. Myocardial infarction associated mortality was 27.2%. Cardiovascular mortality was dominant, including in the landmark analysis beyond 1 year. Multivariate analysis identified significant predictors for long-term cardiovascular mortality: age, history of diabetes mellitus, history of renal insufficiency, history of heart failure, Killip class, and successful pPCI at presentation. A predictive model was built to evaluate the risk of cardiovascular death with a high discrimination value (C-statistic = 0.84). Cardiovascular diseases remain the leading cause of long-term mortality after pPCI in the Central European population. Our novel predictive model provides risk stratification; it could identify patients who would experience the greatest benefit from aggressive secondary prevention measures.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pesl, Ladislav $u Department of Cardiology, Hospital Ceske Budejovice, a.s., Ceske Budejovice, B. Nemcove 585/54, 370 01, Czech Republic
700    1_
$a Neuberg, Marek $u Medtronic Czechia, Partner of INTERCARDIS Project, Prague, Prosecka 852/66, 190 00, Czech Republic
700    1_
$a Tousek, Petr $u Third Faculty of Medicine, Charles University, Prague, Ruska 2411, 100 00, Czech Republic $u Department of Cardiology, University Hospital Kralovske Vinohrady, Prague, Srobarova 50, 100 00, Czech Republic
700    1_
$a Kocka, Viktor $u Third Faculty of Medicine, Charles University, Prague, Ruska 2411, 100 00, Czech Republic $u Department of Cardiology, University Hospital Kralovske Vinohrady, Prague, Srobarova 50, 100 00, Czech Republic
773    0_
$w MED00005247 $t European heart journal supplements : journal of the European Society of Cardiology $x 1520-765X $g Roč. 24, Suppl B (2022), s. B16-B22
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35370501 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100239 $b ABA008
999    __
$a ind $b bmc $g 1816616 $s 1168735
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 24 $c Suppl B $d B16-B22 $e 20220330 $i 1520-765X $m European heart journal supplements $n Eur Heart J Suppl $x MED00005247
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...